1. Conspicuous activated lymphocytic proliferation associated with cytokine-release syndrome after CAR T-cell therapy

   • Russell Wolters
   • Choladda V. Curry

   Images in Hematology 20 September 2018 Pages: 461 - 462

   

2. Lymphadenopathy with coexisting normal architecture in malignant lymphoma

   • Shoji Saito
   • Yoshifumi Ogiso
   • Kazuo Sakashita

   Images in Hematology 06 September 2018 Pages: 463 - 464

   

3. Systematic review of pre-clinical chronic myeloid leukaemia

   • Jew Win Kuan
   • Anselm Ting Su
   • Goro Sashida

   Review Article 14 September 2018 Pages: 465 - 484

   

4. Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis

   • Zaher K. Otrock
   • Brenda J. Grossman
   • Charles S. Eby

   Original Article 24 July 2018 Pages: 485 - 490

5. A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia

   • Yuzuru Kanakura
   • Yukari Shirasugi
   • Chiaki Nakaseko

   Original Article 18 August 2018 Pages: 491 - 498

   

6. Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

   • Ken Ohmachi
   • Kensei Tobinai
   • Kiyoshi Ando

   Original Article 19 July 2018 Pages: 499 - 509

   

7. Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma

   • Yoshihiro Kameoka
   • Tomoaki Akagi
   • Naoto Takahashi

   Original Article 24 July 2018 Pages: 510 - 515

   

8. Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma

   • Jun Nakashima
   • Yoshitaka Imaizumi
   • Yasushi Miyazaki

   Original Article 21 July 2018 Pages: 516 - 523

   

9. Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

   • Kosei Matsue
   • Kyoya Kumagai
   • Kenshi Suzuki

   Original Article 24 July 2018 Pages: 524 - 534

   

10. Comparison of HHV-6 DNA detection in plasma and whole blood in allogeneic hematopoietic stem cell transplant recipients: frequent false-positive results for active HHV-6 infection using whole blood samples

    • Kuniko Takano
    • Masao Ogata
    • Kuniaki Shirao

    Original Article 16 July 2018 Pages: 535 - 542

    

11. Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients

    • Hirozumi Sano
    • Ryoji Kobayashi
    • Kunihiko Kobayashi

    Original Article 23 July 2018 Pages: 543 - 549

12. A unique clinical presentation of de novo acute promyelocytic leukemia as a myeloid sarcoma of the breast

    • Iveta Oravcova
    • Eva Mikuskova
    • Lubos Drgona

    Case Report 21 June 2018 Pages: 550 - 553

    

13. Successful treatment of cytarabine-related neurotoxicity with corticosteroids, a case series

    • Jennifer L. Dotson
    • Muhammad Omer Jamil

    Case Report 26 June 2018 Pages: 554 - 557

    

14. Breakthrough infection of Geotrichum capitatum during empirical caspofungin therapy after umbilical cord blood transplantation

    • Shuki Oya
    • Tsuyoshi Muta

    Case Report 20 June 2018 Pages: 558 - 563

    

15. Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

    • Kosei Matsue
    • Kyoya Kumagai
    • Kenshi Suzuki

    Correction 30 August 2018 Pages: 564 - 564